Paydirt
ANTX
Ticker

AN2 Therapeutics, Inc.

ANTX · Healthcare · AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics

AN2 Therapeutics, Inc. (ANTX), in the Healthcare sector, has 1 disclosed filing on Paydirt over the trailing twelve months from 1 corporate insider: 0 purchases and 1 sale. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 17 and filed Aug 19. The most active filer was Braden Michael Leonard with 2 filings.

Add to watchlist
Filings, ttm
1
0 buys · 1 sell
Traders, ttm
1
1 insider
Volume, ttmiDollar value disclosed in the window
$213K
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Aug 17
Filed Aug 19
ADViAverage daily dollar volume
$1.7M
market data
Share price · 12M
$5.53 (+312.7%)
$6.28$3.66$1.03Sep 22 2025Mar 11Aug 26

Adjusted for splits and dividends.

Volume by month
$2.9M$1.4M$0Oct 2024Apr 2025Oct 2025Apr 2026May 2025 · sells $2.9MJun 2025 · sells $218KAug 2026 · sells $213K
Buys $0 Sells $3.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
BL Braden Michael Leonard 10% owner 2 filings RR Robin Shane Readnour Director 1 filing
Recent filings
Robin Shane ReadnourSALE Director $213K
35,402 sh across 2 lots
Exec Aug 17
Filed Aug 19 · 5:58 PM ET Braden Michael LeonardSALE 10% owner $218K
200,000 sh × $1.09
Exec May 28 2025
Filed Jun 16 2025 · 5:30 PM ET † Braden Michael LeonardSALE 10% owner $2.9M
2,525,000 sh across 3 lots
Exec May 28 2025
Filed May 30 2025 · 5:30 PM ET